← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 1, 1997First marketed drug
Oct 10, 1989First NDA
Oct 10, 1989Last known activity
Mar 31, 2023
Timeline
1980s
- Jan 1, 1980
Hemispherx Biopharma— Founded
- Oct 10, 1989
interferon alfa-n3— NDA Organization
- Oct 10, 1989
interferon alfa-n3— NDA Secondary Org
Drugs by trial phase (11 distinct, 14 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (9 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Marketed drugs (1)
Recent trials (21)
- NCT05592418Lead sponsorPhase 2Mar 31, 2023
- NCT05592418Study directorPhase 2Mar 31, 2023
- NCT05494697Lead sponsorPhase 2Sep 30, 2022
- NCT05494697Study directorPhase 2Sep 30, 2022
- NCT03899987CollaboratorPhase 2Aug 1, 2019
- NCT03734692CollaboratorPhase 1/Phase 2Jan 28, 2019
- NCT02432378CollaboratorPhase 1/Phase 2Jul 1, 2015
- NCT01545141CollaboratorPhase 1/Phase 2Oct 1, 2012
- NCT01591473Study directorPhase 1/Phase 2Apr 1, 2012
- NCT01591473Lead sponsorPhase 1/Phase 2Apr 1, 2012
- NCT00215852Study directorPhase 2Jul 1, 2005
- NCT00215852Lead sponsorPhase 2Jul 1, 2005
- NCT00215826Lead sponsorPhase 2Nov 1, 2004
- NCT00035893Study directorPhase 2May 1, 2001
- NCT00035893Lead sponsorPhase 2May 1, 2001
Details
- Founded
- Philadelphia, PA, US Jan 1, 1980
- First NDA
- Oct 10, 1989
- Last known activity
- Mar 31, 2023